Literature DB >> 6835377

Assembly of two types of tubules with putative cytolytic function by cloned natural killer cells.

E R Podack, G Dennert.   

Abstract

The formation of ultrastructural membrane lesions of varying size during cell mediated cytolysis effected by human peripheral blood leukocytes was recently reported by Dourmashkin et al. and Henkart et al. Using cloned mouse natural killer (NK) cells as effectors and YAC-1 cells or rabbit erythrocytes as targets, we now report two types of membrane lesions with inner diameters of 16 +/- 2 nm and approximately 5 nm, respectively. These lesions arise by membrane insertion of tubular complexes that may be assembled from subunits during the cytolytic reaction. The tubules are detected on target membranes by immune electron microscopy and appear to form transmembrane channels as seen in ultrathin sections. Both tubules are partially purified by membrane extraction with SDS and gel filtration in deoxycholate containing buffer. Based on the correlation of tubule assembly and cytolysis and on their detection on target membranes, we suggest that both types of tubules may be related to cytolysis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6835377     DOI: 10.1038/302442a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  70 in total

Review 1.  Perforin and its role in T lymphocyte-mediated cytolysis.

Authors:  B Lowin; O Krähenbühl; C Müller; M Dupuis; J Tschopp
Journal:  Experientia       Date:  1992-10-15

2.  Perforin activity at membranes leads to invaginations and vesicle formation.

Authors:  Tilen Praper; Andreas F-P Sonnen; Ales Kladnik; Alberto O Andrighetti; Gabriella Viero; Keith J Morris; Emanuela Volpi; Lorenzo Lunelli; Mauro Dalla Serra; Christopher J Froelich; Robert J C Gilbert; Gregor Anderluh
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-15       Impact factor: 11.205

3.  Critical role for perforin and Fas-dependent killing of dendritic cells in the control of inflammation.

Authors:  Min Chen; Kumar Felix; Jin Wang
Journal:  Blood       Date:  2011-10-31       Impact factor: 22.113

4.  Granzymes, cytotoxic granules and cell death: the early work of Dr. Jurg Tschopp.

Authors:  J A Trapani
Journal:  Cell Death Differ       Date:  2011-11-18       Impact factor: 15.828

5.  Perforin/granzyme-dependent and independent mechanisms are both important for the development of graft-versus-host disease after murine bone marrow transplantation.

Authors:  T A Graubert; J F DiPersio; J H Russell; T J Ley
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

6.  Immunological rejection of heart transplant: how lytic granules from cytotoxic T lymphocytes damage guinea pig ventricular myocytes.

Authors:  O Binah; S Marom; I Rubinstein; R B Robinson; G Berke; B F Hoffman
Journal:  Pflugers Arch       Date:  1992-02       Impact factor: 3.657

7.  Perforin polymorphism A91V and susceptibility to B-precursor childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group.

Authors:  P A Mehta; S M Davies; A Kumar; M Devidas; S Lee; T Zamzow; J Elliott; J Villanueva; J Pullen; Y Zewge; A Filipovich
Journal:  Leukemia       Date:  2006-06-22       Impact factor: 11.528

8.  Functional channel formation associated with cytotoxic T-cell granules.

Authors:  J D Young; C F Nathan; E R Podack; M A Palladino; Z A Cohn
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

9.  Rapid loss of perforin and serine protease RNA in cytotoxic lymphocytes exposed to sensitive targets.

Authors:  A Bajpai; B S Kwon; Z Brahmi
Journal:  Immunology       Date:  1991-10       Impact factor: 7.397

10.  Inhibition of intracellular bacterial replication in fibroblasts is dependent on the perforin-like protein (perforin-2) encoded by macrophage-expressed gene 1.

Authors:  Ryan McCormack; Lesley R de Armas; Motoaki Shiratsuchi; Jahir E Ramos; Eckhard R Podack
Journal:  J Innate Immun       Date:  2012-12-15       Impact factor: 7.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.